Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs RingCentral Inc. Class A Common Stock (RNG) Price & Performance

Nuvation Bio Inc. Class A Common StockTrade
RingCentral Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

Nuvation Bio Inc. Class A Common Stock vs RingCentral Inc. Class A Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.22 (market cap $1.74B), while RingCentral Inc. Class A Common Stock trades at $78.58 (market cap $6.54B). The key difference: RingCentral Inc. Class A Common Stock is far larger — about 3.8× Nuvation Bio Inc. Class A Common Stock's market cap, and RingCentral Inc. Class A Common Stock pays a 0.35% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and RingCentral Inc. Class A Common Stock for 0 Days on average.

NUVBRNG
Market Cap
$1.74B$6.54B
Volume
9,289,6191,543,570
Sector
HealthTechnology
52-Week High
$9.54$79.82
52-Week Low
$3.41$24.82
Typical Hold Time
0 Days0 Days
Enterprise Value
$1.33B$7.60B
Dividend Yield
—0.35%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NUVB
100% Buy0% Sell
Avg holding period · 0 Days
RNG
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Nuvation Bio Inc. Class A Common Stock

Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.

Read more on NUVB →

About RingCentral Inc. Class A Common Stock

RingCentral provides cloud-based business communications and contact center solutions. Its platform combines phone, messaging, video meetings, and customer-service tools.

Read more on RNG →